Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
68.2M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
29.7M
-
Shares change
-
+17.4M
-
Total reported value, excl. options
-
$41.7M
-
Value change
-
+$24.4M
-
Number of buys
-
12
-
Number of sells
-
-6
-
Price
-
$1.41
Significant Holders of IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) as of Q3 2023
24 filings reported holding IOBT - IO Biotech, Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
of 68.2M outstanding shares and own 43.48% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (6.17M shares), Novo Holdings A/S (5.75M shares), Samsara BioCapital, LLC (3.64M shares), ARMISTICE CAPITAL, LLC (2.15M shares), MARSHALL WACE, LLP (2.11M shares), Avoro Capital Advisors LLC (2.06M shares), Stonepine Capital Management, LLC (1.98M shares), BANK OF AMERICA CORP /DE/ (1.85M shares), PFM Health Sciences, LP (1.35M shares), and Alyeska Investment Group, L.P. (988K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.